Cited by 1,010Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Wild, Robert A., Carmina, Enrico, Diamanti-Kandarakis, Evanthia, Dokras, Anuja, Escobar-Morreale, Hector F., Futterweit, Walter, Lobo, Rogerio, Norman, Robert J., Talbott, Evelyn, Dumesic, Daniel A.·2010·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2009-2724

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.

Integrity signals

Registry

Crossref · 10.1210/jc.2009-2724

Cites

142 of 142 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457

Show all 146 references

Research works printed but not linked: 1

Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377

Sorted by citations

Items 201–300 of 1,000

Metabolic syndrome — a new definition and management guidelines
Dobrowolski, P., Prejbisz, A., Kuryłowicz, A., Baska, A., Burchardt, P., Chlebus, K., Dzida, G. J., Jankowski, P., Jaroszewicz, J., Jaworski, P., et al. (2022) · Arterial Hypertension · doi:10.5603/ah.a2022.0012 · Cited by 66
Fatty liver index in polycystic ovary syndrome
Lerchbaum, E., Gruber, H., Theiler‐Schwetz, V., Giuliani, A., Möller, R., Pieber, T. R., & Obermayer-Pietsch, B. M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0614 · Cited by 53
Clinical characteristics of polycystic ovary syndrome: investigating differences in White and South Asian women
Mani, H., Davies, M. J., Bodicoat, D. H., Levy, M. J., Gray, L. J., Howlett, T. A., & Khunti, K. K. (2015) · Clinical Endocrinology · doi:10.1111/cen.12784 · Cited by 52
Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china
Huang, J., Ni, R., Chen, X., Huang, L., Mo, Y., & Yang, D. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-142 · Cited by 52
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome
Palomba, S., Falbo, A. I., Russo, T., Rivoli, L., Orio, M., Cosco, A. G., Vero, R., Capula, C., Tolino, A., Zullo, F., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1971 · Cited by 53
Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women
Ha, L., Shi, Y., Zhao, J., Li, T., & Chen, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126505 · Cited by 52
Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study
Ramezani Tehrani, F., Minooee, S., & Azizi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0094 · Cited by 51
Cardiovascular Risk and Subclinical Cardiovascular Disease in Polycystic Ovary Syndrome
Studen, K. B., Sever, M. J., & Pfeifer, M. (2012) · Frontiers of hormone research · doi:10.1159/000341838 · Cited by 51
Prevention of cardiovascular disease in young adults: Focus on gender differences. A collaborative review from the EAS Young Fellows
Antza, C., Gallo, A., Boutari, C., Ershova, A. I., Gürses, K. M., Lewek, J., Mirmaksudov, M., Silbernagel, G., Sandstedt, J., & Lebedeva, А. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117272 · Cited by 70
Hyperandrogenism Induces a Proinflammatory TNFα Response to Glucose Ingestion in a Receptor-Dependent Fashion
González, F., Sia, C. L., Bearson, D. M., & Blair, H. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4109 · Cited by 51
Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome
Magnussen, L. V., Mumm, H., Andersen, M., & Glintborg, D. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.035 · Cited by 51
Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome
Lambrinoudaki, I. V. (2010) · Maturitas · doi:10.1016/j.maturitas.2010.09.005 · Cited by 51
31. Polycystic ovary syndrome and the metabolic syndrome
Hunter, T., & Hart, R. J. (2014) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-767-7.031 · Cited by 51
Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls
Glintborg, D., Petersen, M. H., Ravn, P., Hermann, A. P., & Andersen, M. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12964 · Cited by 53
Hypothalamic neuroglial plasticity is regulated by anti-Müllerian hormone and disrupted in polycystic ovary syndrome
Barbotin, A., Mimouni, N. E. H., Kuchcinski, G., Lopes, R., Viard, R., Rasika, S., Mazur, D., Silva, M. S. B., Simon, V., Boursier, A., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104535 · Cited by 53
Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome
Çalan, M., Yılmaz, Ö., Küme, T., Kocabaş, G. Ü., Senses, P. Y., Senses, Y. M., Temür, M., & Çalan, Ö. G. (2016) · Endocrine · doi:10.1007/s12020-016-0875-z · Cited by 50
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis
Yılmaz, B., Vellanki, P., Ata, B., & Yıldız, B. O. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.04.024 · Cited by 53
Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort
Kazemi, M., Pierson, R. A., Lujan, M. E., Chilibeck, P. D., McBreairty, L. E., Gordon, J. J., Serrao, S. B., Zello, G. A., & Chizen, D. R. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.11.026 · Cited by 51
THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0585 · Cited by 49
Proteomic and metabolomic approaches to the study of polycystic ovary syndrome
Insenser, M. R., Montes‐Nieto, R., Murri, M., & Escobar-Morreale, H. F. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.02.009 · Cited by 49
Self-citation
Circulating osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in polycystic ovary syndrome: relationships to insulin resistance and endothelial dysfunction
Pepene, C. E., Ilie, I. R. P., Marian, I., & Duncea, I. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0720 · Cited by 49
Polycystic ovarian syndrome: clinical and biological diagnosis
Bachelot, A. (2016) · Annales de biologie clinique · doi:10.1684/abc.2016.1184 · Cited by 49
Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study
Fatima, Q., Amin, S., Kawa, I. A., Jeelani, H., Manzoor, S., Rizvi, S. M., & Rashid, F. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.032 · Cited by 52
Hyperandrogenic Oligomenorrhea and Metabolic Risks Across Menopausal Transition
Polotsky, A. J., Allshouse, A. A., Crawford, S. L., Harlow, S. D., Khalil, N., Kazlauskaite, R., Santoro, N., & Legro, R. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4170 · Cited by 48
Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
Seeber, B., Morandell, E., Lunger, F., Wildt, L., & Dieplinger, H. (2014) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-12-88 · Cited by 48
Neurokinin B Exerts Direct Effects on the Ovary to Stimulate Estradiol Production
Qi, X., Salem, M., Zhou, W., Sato-Shimizu, M., Ye, G., Smitz, J. E. J., & Peng, C. (2016) · Endocrinology · doi:10.1210/en.2016-1354 · Cited by 48
Independent and Additive Effects of Coenzyme Q10 and Vitamin E on Cardiometabolic Outcomes and Visceral Adiposity in Women With Polycystic Ovary Syndrome
Izadi, A., Shirazi, S., Taghizadeh, S., & Gargari, B. P. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.04.004 · Cited by 48
Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: secondary analyses of a randomized controlled trial
Stener‐Victorin, E., Baghaei, F., Holm, G., Janson, P. O., Olivecrona, G., Lönn, M., & Mannerås-Holm, L. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.010 · Cited by 48
Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled Trials
Du, Q., Yang, S., Wang, Y.-J., Wu, B., Zhao, Y.-Y., & Fan, B. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0044-6 · Cited by 47
Aberrant GDF9 Expression and Activation Are Associated With Common Human Ovarian Disorders
Simpson, C. M., Robertson, D. M., Al-Musawi, S. L., Heath, D. A., McNatty, K. P., Ritter, L. J., Mottershead, D. G., Gilchrist, R. B., Harrison, C. A., & Stanton, P. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3949 · Cited by 47
Nitric oxide‐mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training
Sprung, V. S., Cuthbertson, D. J., Pugh, C. J. A., Daousi, C., Atkinson, G., Aziz, N., Kemp, G. J., GREEN, D. J., Cable, N. T., & Jones, H. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.246918 · Cited by 47
Comparison of diabetes mellitus and insulin resistance screening methods for women with polycystic ovary syndrome
Hurd, W. W., Abdel-Rahman, M. Y., Ismail, S. A., Abdellah, M. A., Schmotzer, C. L., & Sood, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.07.002 · Cited by 46
Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype
Armeni, E., Stamatelopoulos, K. S., Rizos, D., Georgiopoulos, G., Kazani, M. V., Kazani, A., Kolyviras, A., Stellos, K., Panoulis, K. P. C., Alexandrou, A. P., et al. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283630362 · Cited by 46
Exercise Training in Polycystic Ovarian Syndrome Enhances Flow-Mediated Dilation in the Absence of Changes in Fatness
Sprung, V. S., Cuthbertson, D. J., Pugh, C. J. A., Aziz, N., Kemp, G. J., Daousi, C., GREEN, D. J., Cable, N. T., & Jones, H. (2013) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31829ba9a1 · Cited by 46
Sex-Based Differences in Vascular Function
Miller, V. M. (2010) · Women s Health · doi:10.2217/whe.10.53 · Cited by 47
The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS
Pelanis, R., Mellembakken, J. R., Poromaa, I. S., Ravn, P., Morin-Papunen, L. C., Tapanainen, J. S., Piltonen, T., Puurunen, J., Hirschberg, A. L., Fedorcsák, P., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex294 · Cited by 46
Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring
Manti, M., Fornes, R., Pironti, G., Haworth, S. M., Zhuge, Z., Benrick, A., Carlström, M., Andersson, D. C., & Stener‐Victorin, E. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz180 · Cited by 47
Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update
Katsiki, N., & Hatzitolios, A. I. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32833e1264 · Cited by 45
Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations
Huang, C., Tien, Y.-J., Chen, M., Chen, C., Ho, H., & Yang, Y. (2015) · Human Reproduction · doi:10.1093/humrep/dev010 · Cited by 45
Cardiovascular risk factors and events in women with androgen excess
Μacut, D., Antić, I. B., & Bjekić-Macut, J. (2014) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0215-1 · Cited by 45
The regulatory effect of Genistein on granulosa cell in ovary of rat with PCOS through Bcl-2 and Bax signaling pathways
Chi, X., Zhang, T., Xiao-Li, C. H. U., Jing-Long, Z. H. E. N., & Zhang, D. (2018) · Journal of Veterinary Medical Science · doi:10.1292/jvms.17-0001 · Cited by 45
Hypertension in Polycystic Ovary Syndrome: Novel Insights
Μacut, D., Mladenović, V., Bjekić-Macut, J., Livadas, S., Stanojlović, O. P., Hrnčić, D., Rašić-Marković, A., Milutinović, D. V., & Andric, Z. G. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190531071422 · Cited by 50
Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis
Gariani, K., Hugon‐Rodin, J., Philippé, J., Righini, M., & Blondon, M. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.11.019 · Cited by 45
The effect of concentrated pomegranate juice consumption on risk factors of cardiovascular diseases in women with polycystic ovary syndrome: A randomized controlled trial
Abedini, M., Tehrani, H. G., Tarrahi, M. J., & Amani, R. (2020) · Phytotherapy Research · doi:10.1002/ptr.6820 · Cited by 46
Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis
Bayona, A., Martínez-Vaello, V., Zamora, J., Nattero-Chávez, L., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmac011 · Cited by 44
Self-citation
Hyperandrogenism and Insulin Resistance, Not Changes in Body Weight, Mediate the Development of Endothelial Dysfunction in a Female Rat Model of Polycystic Ovary Syndrome (PCOS)
Hurliman, A. K., Brown, J. K., Maille, N., Mandalà, M., Casson, P. R., & Osol, G. (2015) · Endocrinology · doi:10.1210/en.2015-1159 · Cited by 44
Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., Μacut, D., Delkos, D., Betsas, G., Misichronis, G., & Katsikis, I. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.11.041 · Cited by 44
Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome
Nitsche, K., & Ehrmann, D. A. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.08.001 · Cited by 48
Four-year weight outcomes of laparoscopic gastric bypass surgery and adjustable gastric banding among multiethnic adolescents
Cruz-Munoz, N. F. D. L., Messiah, S. E., Cabrera, J. C., Torres, C., Cuesta, M., Lopez‐Mitnik, G., & Arheart, K. L. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2010.06.004 · Cited by 44
The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome
Tavares, A., & Barros, R. C. D. R. (2019) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0038-1676568 · Cited by 44
Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?
Dokras, A., & Witchel, S. F. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4190 · Cited by 43
Self-citation
The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome
Panidis, D., Tziomalos, K., Papadakis, E., Chatzis, P., Kandaraki, E. A., Tsourdi, E. A., & Katsikis, I. (2014) · Clinical Endocrinology · doi:10.1111/cen.12305 · Cited by 43
The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
de Melo, A. S., Vieira, C. S., Romano, L. G. M., Ferriani, R. A., & Navarro, P. A. (2011) · Reproductive Sciences · doi:10.1177/1933719111414205 · Cited by 43
Targets to treat metabolic syndrome in polycystic ovary syndrome
Mahalingaiah, S., & Diamanti‐Kandarakis, E. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1101067 · Cited by 44
Self-citation
Polycystic Ovary Syndrome and Insulin: Our Understanding in the Past, Present and Future
Mayer, S., Evans, W. S., & Nestler, J. E. (2015) · Women s Health · doi:10.2217/whe.14.73 · Cited by 46
Meta-inflammation and cardiometabolic disease in obesity: Can heat therapy help?
Ely, B. R., Clayton, Z. S., McCurdy, C. E., Pfeiffer, J. D., & Minson, C. T. (2017) · Temperature · doi:10.1080/23328940.2017.1384089 · Cited by 46
In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome?
Abbott, D. H., Kraynak, M., Dumesic, D. A., & Levine, J. E. (2019) · Frontiers of Hormone Research · doi:10.1159/000494899 · Cited by 42
Self-citation
Polycystic Ovary Syndrome Is Associated with Higher Left Ventricular Mass Index: The CARDIA Women's Study
Wang, E. T., Ku, I. A., Shah, S. J., Daviglus, M. L., Schreiner, P. J., Konety, S., Williams, O. D., Siscovick, D. S., & Bibbins-Domingo, K. B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1597 · Cited by 42
Ovulation as danger signaling event of innate immunity
Spanel‐Borowski, K. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.12.008 · Cited by 43
Polycystic ovary syndrome: chemical pharmacotherapy
Rocca, M. L., Venturella, R., Mocciaro, R., Cello, A. D., Sacchinelli, A., Russo, V. M., Trapasso, S., Zullo, F., & Morelli, M. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1047344 · Cited by 41
Significantly lengthened telomere in granulosa cells from women with polycystic ovarian syndrome (PCOS)
Wei, D., Xie, J., Yin, B., Hao, H., Song, X., Liu, Q., Zhang, C., & Sun, Y. (2017) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-0945-z · Cited by 42
Polycystic Ovary Syndrome and Hyperandrogenic States
Chang, R. J., & Dumesic, D. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00021-4 · Cited by 41
Self-citation
Pathophysiological effects of androgens on the female vascular system
Stone, T. M., & Stachenfeld, N. S. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00323-6 · Cited by 45
Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women
Lerchbaum, E., Theiler‐Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1035 · Cited by 44
Abnormal infant islet morphology precedes insulin resistance in PCOS-like monkeys
Nicol, L. E., O’Brien, T. D., Dumesic, D. A., Grogan, T., Tarantal, A. F., & Abbott, D. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106527 · Cited by 41
Self-citation
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41
Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome
Wan, Z., Zhao, J., Ye, Y., Sun, Z., Li, K., Chen, Y., Fang, Y., Zhang, Y., Lin, J., Sun, P., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae066 · Cited by 43
Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome
Androulakis, I., Kandaraki, E., Christakou, C., Karachalios, A., Marinakis, E., Paterakis, T., & Diamanti-Kandarakis, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12447 · Cited by 46
Self-citation
Association between menstrual cycle irregularities and endocrine and metabolic characteristics of the polycystic ovary syndrome
Panidis, D., Τζιόμαλος, Κ., Chatzis, P., Papadakis, E. P., Delkos, D., Tsourdi, E. A., Kandaraki, E., & Katsikis, I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0655 · Cited by 41
Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome
Feldman, R., O’Neill, K. E., Butts, S. F., & Dokras, A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.009 · Cited by 41
Self-citation
The Source of Polycystic Ovarian Syndrome
Raperport, C., & Homburg, R. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119871467 · Cited by 43
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS
Savastano, S., Valentino, R., Somma, C. D., Orio, F., Pivonello, C., Passaretti, F., Brancato, V., Formisano, P., Colao, A., Bèguinot, F., et al. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-84 · Cited by 41
Polycystic Ovary Syndrome
McCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmc1610000 · Cited by 43
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study
Chang, A. Y., Oshiro, J., Ayers, C. R., & Auchus, R. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12986 · Cited by 40
Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents with Polycystic Ovary Syndrome.
Vine, D., Wang, Y., Jetha, M., Ball, G., & Proctor, S. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2854 · Cited by 40
Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome
Jové, M., Pradas, I., Naudí, A., Rovira‐Llopis, S., Bañuls, C., Rocha, M., Portero‐Otín, M., Hernández‐Mijares, A., Víctor, V. M., & Pamplona, R. (2017) · Oncotarget · doi:10.18632/oncotarget.23393 · Cited by 40
A landscape analysis of the potential role of polyphenols for the treatment of Polycystic Ovarian Syndrome (PCOS)
Rani, R., Hajam, Y. A., Kumar, R., Bhat, R. A., Rai, S., & Rather, M. A. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100161 · Cited by 45
Factors Contributing to Initial Weight Loss Among Adolescents with Polycystic Ovary Syndrome
Geier, L. M., Bekx, M. T., & Connor, E. L. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.06.008 · Cited by 40
Effect of Metformin compared with hypocaloric diet on serum C‐reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome
Esfahanian, F., Zamani, M. M., Heshmat, R., & Moini nia, F. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2012.02051.x · Cited by 38
Prevalence and ultrasound features of polycystic ovaries in young unmarried Saudi females
Guraya, S. (2013) · Journal of Microscopy and Ultrastructure · doi:10.1016/j.jmau.2013.06.002 · Cited by 40
Polycystic ovary syndrome in adult women
Ortiz-Flores, A. E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.02.019 · Cited by 40
Self-citation
Gut Microbes in Polycystic Ovary Syndrome and Associated Comorbidities; Type 2 Diabetes, Non-Alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease (CVD), and the Potential of Microbial Therapeutics
Singh, V., Mahra, K., Jung, D.-R., & Shin, J. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10262-y · Cited by 40
Ovarian infertility is associated with cardiovascular disease risk factors in later life: A Japanese cross-sectional study
Kurabayashi, T., Mizunuma, H., Kubota, T., & Hayashi, K. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.08.015 · Cited by 40
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment
Amato, M. C., Guarnotta, V., Forti, D., Donatelli, M., Dolcimascolo, S., & Giordano, C. S. D. S. (2013) · Human Reproduction · doi:10.1093/humrep/det105 · Cited by 39
Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
Jacewicz‐Święcka, M., & Kowalska, I. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3054 · Cited by 39
The relationship between polycystic ovary syndrome and insulin resistance from 1983 to 2022: A bibliometric analysis
Chen, T., Yu, Y., Jia, F., Luan, P., & Liu, X. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.960965 · Cited by 37
Elevated levels of interleukin-18 are associated with several indices of general and visceral adiposity and insulin resistance in women with polycystic ovary syndrome
Kabakchieva, P., Gateva, A., Velikova, T. V., Georgiev, T., Yamanishi, K., Okamura, H., & Kamenov, Z. A. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000442 · Cited by 37
The role of sex differences in cardiovascular, metabolic, and immune functions in health and disease: a review for “Sex Differences in Health Awareness Day”
McClements, L., Kautzky‐Willer, A., Kararigas, G., Ahmed, S. B., & Stallone, J. N. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00714-7 · Cited by 48
Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome
Okoroh, E. M., Boulet, S. L., George, M. G., & Hooper, W. C. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.10.022 · Cited by 37
What do we know about metabolic syndrome in adolescents with PCOS?
Cırık, D. A., & Dilbaz, B. (2014) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2014.95776 · Cited by 38
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS
Genazzani, A. D. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000140 · Cited by 36
Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial
Alpañés, M., Álvarez‐Blasco, F., Fernández‐Durán, E., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0516 · Cited by 37
Self-citation
Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome
Liu, S., Hu, W., He, Y., Li, L., Liu, H., Gao, L., Yang, G., & Liao, X. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-0538-1 · Cited by 37
A Review of the Impact of Bariatric Surgery in Women With Polycystic Ovary Syndrome
Lee, R. H., Mathew, C. J., Jose, M. T., Elshaikh, A. O., Shah, L., & Cancarevic, I. (2020) · Cureus · doi:10.7759/cureus.10811 · Cited by 37
Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome
Alpañés, M., Luque‐Ramírez, M., Martínez-García, M. Á., Fernández‐Durán, E., Álvarez‐Blasco, F., & Escobar-Morreale, H. F. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.12.105 · Cited by 37
Self-citation
Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
Cignarella, A., Mioni, R., Sabbadin, C., Dassie, F., Parolin, M., Vettor, R., Barbot, M., & Scaroni, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249554 · Cited by 36
Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor
Marinkovic-Radosevic, J., Cigrovski Berkovic, M., Kruezi, E., Bilic-Curcic, I., & Mrzljak, A. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.932 · Cited by 35
Polycystic Ovary Syndrome as Metabolic Disease: New Insights on Insulin Resistance
Genazzani, A. D., & Genazzani, A. R. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.71 · Cited by 40
Vascular function in the diagnostic categories of polycystic ovary syndrome
Moran, L., Cameron, J. D., Strauss, B. J., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der159 · Cited by 36

Authors: Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
Affiliations: OU Health (US)
University of Palermo (IT)
University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
University of Pennsylvania (US)
Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
Icahn School of Medicine at Mount Sinai (US)
Columbia University (R.L.), New York, New York 10027
The University of Adelaide (AU)
University of Pittsburgh (US)
University of Wisconsin–Madison (US)
Corresponding author: Carmina, Enrico
ORCID: Wild, Robert A.
Carmina, Enrico
Dokras, Anuja
Norman, Robert J.
Talbott, Evelyn
Dumesic, Daniel A.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2010-05-01
Volume: 95
Issue: 5
Pages: 2038-2049
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2009-2724
OpenAlex: W2105749473
Semantic Scholar: 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
Cited by: 1,010
References: 146
Citations by year: 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
FWCI: 79.63
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks